Foxp3 is required for the generation and activity of CD4+CD25+ regulatory T (T reg) cells, which are important controllers of autoimmunity, including type-1 diabetes. To determine where T reg cells affect the diabetogenic cascade, we crossed the Foxp3 scurfy mutation, which eliminates T reg cells, with the BDC2.5 T cell receptor (TCR) transgenic mouse line. In this model, the absence of T reg cells did not augment the initial activation or phenotypic characteristics of effector T cells in the draining lymph nodes, nor accelerate the onset of T cell infiltration of the pancreatic islets. However, this insulitis was immediately destructive, causing a dramatic progression to overt diabetes. Microarray analysis revealed that T reg cells in the insulitic lesion adopted a gene expression program different from that in lymph nodes, whereas T reg cells in draining or irrelevant lymph nodes appeared very similar. Thus, T reg cells primarily impinge on autoimmune diabetes by reining in destructive T cells inside the islets, more than during the initial activation in the draining lymph nodes.
Skip Nav Destination
Article navigation
21 November 2005
Article Contents
Article|
November 21 2005
Where CD4 + CD25 + T reg cells impinge on autoimmune diabetes
Zhibin Chen,
Zhibin Chen
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Search for other works by this author on:
Ann E. Herman,
Ann E. Herman
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Search for other works by this author on:
Michael Matos,
Michael Matos
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Search for other works by this author on:
Diane Mathis,
Diane Mathis
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Search for other works by this author on:
Christophe Benoist
Christophe Benoist
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Search for other works by this author on:
Zhibin Chen
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Ann E. Herman
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Michael Matos
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Diane Mathis
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
Christophe Benoist
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215
CORRESPONDENCE Christophe Benoist and Diane Mathis: [email protected]
Abbreviations used in this paper: 7AAD, 7-aminoactinomycin; BrdU, 5-bromo-2-deoxyuridine; CFSE, carboxyfluorescein succinimide ester; MLN, mesenteric LN; NOD, nonobese diabetic; PLN, pancreatic LN; T1D, type-1 diabetes; T eff, effector T cell; T reg, regulatory T cell.
Z. Chen and A.E. Herman contributed equally to this work.
A.E. Herman's present address is Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121.
Received:
July 13 2005
Accepted:
October 06 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 202 (10): 1387–1397.
Article history
Received:
July 13 2005
Accepted:
October 06 2005
Citation
Zhibin Chen, Ann E. Herman, Michael Matos, Diane Mathis, Christophe Benoist; Where CD4+CD25+ T reg cells impinge on autoimmune diabetes . J Exp Med 21 November 2005; 202 (10): 1387–1397. doi: https://doi.org/10.1084/jem.20051409
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement